Skip to Content

Orphenadrine Pregnancy and Breastfeeding Warnings

Orphenadrine is also known as: Antiflex, Banflex, Flexoject, Flexon, Mio-Rel, Myolin, Norflex, Norflex Injectable, Orfro, Orphenate

Medically reviewed on March 10, 2017

Orphenadrine Pregnancy Warnings

Orphenadrine has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been reported. There are no controlled data in human pregnancy. Orphenadrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Orphenadrine Breastfeeding Warnings

There are no data on the excretion of orphenadrine into human milk.

See references

References for pregnancy information

  1. "Product Information. Norflex (orphenadrine)." 3M Pharmaceuticals, St. Paul, MN.

References for breastfeeding information

  1. "Product Information. Norflex (orphenadrine)." 3M Pharmaceuticals, St. Paul, MN.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide